Assertio Holdings Inc (ASRT)
1.02
+0.01
(+0.99%)
USD |
NASDAQ |
May 16, 16:00
1.015
0.00 (0.00%)
After-Hours: 20:00
Assertio Holdings Free Cash Flow: 34.40M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 34.40M |
| December 31, 2023 | 48.98M |
| September 30, 2023 | 70.07M |
| June 30, 2023 | 77.53M |
| March 31, 2023 | 73.89M |
| December 31, 2022 | 78.60M |
| September 30, 2022 | 56.03M |
| June 30, 2022 | 50.64M |
| March 31, 2022 | 37.18M |
| December 31, 2021 | 5.523M |
| September 30, 2021 | -4.59M |
| June 30, 2021 | -23.68M |
| March 31, 2021 | -44.74M |
| December 31, 2020 | -65.58M |
| September 30, 2020 | -51.70M |
| June 30, 2020 | -4.262M |
| March 31, 2020 | 36.74M |
| December 31, 2019 | 88.99M |
| September 30, 2019 | 95.34M |
| June 30, 2019 | 129.89M |
| March 31, 2019 | 121.15M |
| December 31, 2018 | 66.99M |
| September 30, 2018 | 79.91M |
| June 30, 2018 | 9.085M |
| March 31, 2018 | 18.99M |
| Date | Value |
|---|---|
| December 31, 2017 | 61.50M |
| September 30, 2017 | 75.30M |
| June 30, 2017 | 95.61M |
| March 31, 2017 | 100.06M |
| December 31, 2016 | 68.40M |
| September 30, 2016 | 68.42M |
| June 30, 2016 | 100.11M |
| March 31, 2016 | 112.37M |
| December 31, 2015 | 125.66M |
| September 30, 2015 | 88.10M |
| June 30, 2015 | 38.60M |
| March 31, 2015 | 6.628M |
| December 31, 2014 | -56.52M |
| September 30, 2014 | -61.05M |
| June 30, 2014 | -46.38M |
| March 31, 2014 | -52.71M |
| December 31, 2013 | 7.792M |
| September 30, 2013 | -1.547M |
| June 30, 2013 | 8.938M |
| March 31, 2013 | -31.70M |
| December 31, 2012 | -37.86M |
| September 30, 2012 | -42.18M |
| June 30, 2012 | -76.49M |
| March 31, 2012 | -34.33M |
| December 31, 2011 | 56.95M |
Free Cash Flow Range, Past 5 Years
-65.58M
Minimum
Dec 2020
129.89M
Maximum
Jun 2019
34.46M
Average
43.08M
Median
Free Cash Flow Benchmarks
| Ocular Therapeutix Inc | -87.11M |
| Vertex Pharmaceuticals Inc | 3.479B |
| Cormedix Inc | -45.70M |
| Verastem Inc | -94.50M |
| CytomX Therapeutics Inc | -92.34M |